Contemporary medical, device, and surgical therapies for obesity in adults
The goal of obesity management is to improve health. Sustained weight loss of more than
10% overall bodyweight improves many of the complications associated with obesity (eg …
10% overall bodyweight improves many of the complications associated with obesity (eg …
Why does obesity cause diabetes?
The accumulation of an excessive amount of body fat can cause type 2 diabetes, and the
risk of type 2 diabetes increases linearly with an increase in body mass index. Accordingly …
risk of type 2 diabetes increases linearly with an increase in body mass index. Accordingly …
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Obesity is now recognised as a disease that is associated with serious morbidity and
increased mortality. One of its main metabolic complications is type 2 diabetes, as the two …
increased mortality. One of its main metabolic complications is type 2 diabetes, as the two …
Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
Background Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but
few effective long-term treatments are available. In cardiovascular trials of inhibitors of …
few effective long-term treatments are available. In cardiovascular trials of inhibitors of …
Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
Background No data from randomised controlled trials of metabolic surgery for diabetes are
available beyond 5 years of follow-up. We aimed to assess 10-year follow-up after surgery …
available beyond 5 years of follow-up. We aimed to assess 10-year follow-up after surgery …
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications …
D Eisenberg, SA Shikora, E Aarts, A Aminian… - 2023 - Springer
Major updates to 1991 National Institutes of Health guidelines for bariatric surgery Metabolic
and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI)> …
and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI)> …
GLP-1 agonist to treat obesity and prevent cardiovascular disease: what have we achieved so far?
MR Pedrosa, DR Franco, HW Gieremek… - Current atherosclerosis …, 2022 - Springer
Abstract Purpose of Review To discuss evidence supporting the use of glucagon-like
peptide 1 receptor agonists (GLP-1RA) to treat obesity and their role as a cardioprotective …
peptide 1 receptor agonists (GLP-1RA) to treat obesity and their role as a cardioprotective …
Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational …
Background Weight loss trajectories after bariatric surgery vary widely between individuals,
and predicting weight loss before the operation remains challenging. We aimed to develop a …
and predicting weight loss before the operation remains challenging. We aimed to develop a …
Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus
NG Docherty, CW le Roux - Nature Reviews Nephrology, 2020 - nature.com
Bariatric surgery is an effective therapy for obesity, hypertension and type 2 diabetes
mellitus that is refractory to maximal medical therapy. Results of long-term cohort studies …
mellitus that is refractory to maximal medical therapy. Results of long-term cohort studies …